Understand what people are taking.
Browse medicines, supplements, herbs, and health foods. Each profile brings community reports and linked research into one clear view.
Browse medicines, supplements, herbs, and health foods. Each profile brings community reports and linked research into one clear view.
Beetroot juice and concentrated beetroot 'shots' are the main dietary source of inorganic nitrate, which the body turns into nitrite and nitric oxide, a signal that relaxes blood vessels. Meta-analyses of randomised trials find it lowers systolic (upper) blood pressure by about 3.5 to 5 mmHg. In exercise it lengthens time to exhaustion and raises power output a little, but pooled time-trial results show little or no benefit. The evidence on this page is about the nitrate effect; most trials used beetroot juice or nitrate salts.
9 of 11 results reported a benefit, from 5 published studies.
5 studies, including a review of trials
These are the figures the studies reported, not a prediction for any one person. Where several studies measured the same thing in the same unit, we show a simple average and say so. Every individual result is listed below.
See every resultCardiovascular health — blood pressure, cholesterol, heart function, and circulation.
Also known as: Beetroot juice, Beta vulgaris, Dietary nitrate, Inorganic nitrate
Every published result for this pair, extracted and audited.
These charts group published studies by what they reported and how they were run — green marks studies that reported a benefit for this pairing. Tiers run from pooled analyses of many trials (strongest) to one-off observational reports.
Direction of reported outcomes for Beetroot (dietary nitrate) in heart health.
Study designs behind these findings.
Hand-selected PubMed studies, linked to the originals.
Ordered by strength of evidence, then result direction.
01Taurine supplementation as a therapeutic strategy for cellular senescence and chronic inflammation in long COVID: a systematic review and meta-analysisWang K, et al. · BMC infectious diseases · 2026PMID 41803812 ↗02Energy Drinks as the Legal Cocaine? A Comparative Review of Cardiac Physiopathological and Histopathological PatternsGhamlouch A, et al. · Cardiovascular toxicology · 2025PMID 41266869 ↗03Evaluating the efficacy of ubiquinol in heart failure patients: a systematic review and meta-analysisQazi SU, et al. · Future cardiology · 2024PMID 39049769 ↗04Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysisTzang CC, et al. · Nutrition journal · 2024PMID 39148075 ↗Be the first to share what you noticed with Beetroot (dietary nitrate) for heart health. Why counts start empty.
Every measured outcome, one row per finding - numbers exactly as reported.
| Study | Design | n | Duration | Outcome measured | Reported result | Direction |
|---|---|---|---|---|---|---|
| PMID 39069465 2024 | Systematic review | 349 | - | 24-h BP outcomes | reported qualitatively | No benefit |
| PMID 39069465 2024 | Systematic review | 349 | - | clinical diastolic BP | reported qualitatively | No benefit |
| PMID 39069465 2024 | Systematic review | 349 | - | clinical systolic BP | -5.31 mmHg (95% CI -7.46, -3.16) | Benefit |
| PMID 30400267 2018 | Systematic review | - | - | Blood pressure (11 RCTs, narrative synthesis) | reported qualitatively | Benefit |
| PMID 33905826 2021 | Meta-analysis | - | - | Diastolic blood pressure (DBP) | -2.62 mmHg (95% confidence interval: -3.86 to -1.37; P < 0.005) | Benefit |
| PMID 33905826 2021 | Meta-analysis | - | - | Systolic blood pressure (SBP) | -3.90 mmHg (95% confidence interval: -5.23 to -2.57; P < 0.001) | Benefit |
| PMID 29141968 2017 | Meta-analysis | - | - | Resting diastolic blood pressure | -1.32 mm Hg (95% CI: -1.97, -0.68 mm Hg) | Benefit |
| PMID 29141968 2017 | Meta-analysis | - | - | Resting systolic blood pressure | -3.55 mm Hg (95% CI: -4.55, -2.54 mm Hg) | Benefit |
| PMID 29141968 2017 | Meta-analysis | - | - | Systolic blood pressure, studies of 14 days or longer vs shorter studies | -5.11 compared with -2.67 mm Hg | Benefit |
| PMID 23596162 2013 | Meta-analysis | 254 | 2 h to 15 d | diastolic BP | -1.1 mm Hg ((95% CI: -2.2, 0.1); P = 0.06) | Benefit |
| PMID 23596162 2013 | Meta-analysis | 254 | 2 h to 15 d | systolic BP | -4.4 mm Hg ((95% CI: -5.9, -2.8); P < 0.001) | Benefit |